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1. Introduction 
In human plasma, testosterone, stradiol and 17@- 
hydroxy-5o-androstan-3-one (androstanolone or 5o- 
dihydrotestosterone) are mainly bound to the ‘Sex 
Steroid-Binding Plasma Protein’, SBP [ 1,2] . SBP was 
purified to homogeneity using either biospecific 
adsorbents [3-51 or conventional purification 
methods [5]. Some physicochemical parameters of
this protein have been determined, but a specific 
antiserum to SBP has not yet been reported. 
Crude anti-SBP antisera c n be used to check SBP 
preparations atdifferent purification steps, but specific 
antisera re required to set up SBP immunoassays and 
radioimmunoassays, and for immunohistochemical 
investigations. 
The present work will describe the preparation of 
anti-SBP antisera in rabbits or guinea-pigs. SBP showed 
high antigenicity but the resulting antisera contained 
contaminating antibodies. Immunoadsorption to 
insolubilized contaminating antigens allowed us to 
obtain an anti-SBP antiserum, the specificity of which 
was verified by immunoelectrophoresis and double 
immunodiffusion. 
Abbreviations: SBP Sex steroid-binding plasma protein, PBS 
0.01 M phosphate buffered saline, 0.15 M NaCl, pH 7.3, IgG 
rG immunoglobulin, PAGE polyacrylamide gel electrophoresis, 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis, R-TeBG Rabbit testosterone-binding globulin 
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Some preliminary information was presented in a 
report to the Vth International Congress of Endo- 
crinology [6] . 
2. Materials and methods 
2.1. Chemicals 
5a- [ 1 ,2-3H] androstanolone (47 Ci/mM) was 
obtained from Radiochemical Centre Amersham, pure 
transferrin and pure IgG from Behringwerke, (Marburg, 
FRG) agarose (Indubiose A 37) from I’Industrie Biolo- 
gique Francaise (Paris), Ultrogels ACA 34 and 44 
from LKB (Uppsala, Sweden), acrylamide (Biogel 
P300-400 mesh) from Biorad (Richmond, Calif.), 
Freund’s Complete and Incomplete Adjuvants from 
DIFCO (Detroit, Mich.). 
2.2. Preparation of putified SBP 
Partially purified SBP was obtained from late 
pregnancy human plasma after ammonium sulfate 
precipitation (42% saturation), affinity chromato- 
graphy on 3 O-succinyl 17P-estradiol ethylene-diamine 
acrylamide, ACA 44 gel-filtration and isoelectric focus- 
ing. The purified protein showed a single band in 
PAGE (7.5% total acrylamide concentration and 2.6% 
cross-linking agent) according to Davis [7] . It was 
known that SBP and transferrin are not separated in
such a system [8] . Even in those SBP preparations 
giving only one stained band in PAGE at different 
acrylamide concentrations, four protein bands were 
detected in SDS-PAGE [ 51. 
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The purification of SBP was completely achieved 
by repeated ACA 44 gel-filtrations and by an addi- 
tional isoelectric focusing. Only one stained protein 
band was then obtained in SDS-PAGE, and one 
precipitin arc in immunoelectrophoresis against crude 
antiserum [5]. 
2.3. Production of antisera 
Four rabbits (adult males, Fauve de Bourgogne 
breed) and two guinea-pigs (EVIC-CEBA, conventional 
tricolor guinea-pigs) were immunized according to the 
procedure used by Vaitukaitis [9] . 
Partially purified SBP (100 fig/rabbit, 50 pg/guinea- 
pig) was emulsified in 2 ml Freund’s Complete Adju- 
vant and was injected at 1 O-20 dorsal intradermal and 
two subscapular sites. Booster injections of the same 
amount of partially purified SBP, emulsified in 2 ml 
of Freund’s Incomplete Adjuvant were given eight 
weeks later. Ten days later, blood was removed by 
puncture of the marginal ear vein for rabbits and by 
cardiac puncture for guinea pigs. The sera were filtered 
on Millipore (0.45 pm) filters. One ml aliquots of anti- 
sera and of preimmune sera were stored at -38°C. 
Subsequent booster injections of highly purified SBP 
were given monthly for eight months. 
2.4. Double immunodiffusion and immunoelectro- 
phoretic analyses 
Agarose, 1.4%, in PBS with 0.01% sodium azide 
was used in double immunodiffusion plates according 
to Ouchterlony [IO] . Immunoelectrophoretic analysis, 
using agarose-gel concentration of 1.3% in 0.1 M 
barbital buffer, pH 8.6, were performed according to 
Grabar [ 111 as modified by Scheidegger [121. The 
electrophoresis was run at 4°C at 250-260 V for 
3 trays of agarose-gel on microscope slides under 
10 mA. The tank buffer was 0.4 M barbital buffer, 
pH 8.6, with bromophenol blue as tracking dye. The 
plates were stained with Coomassie Brilliant Blue for 
75 s at 37°C and were destained according to Weber 
P31. 
2.5. Detection of antibodies against SBP 
Human late pregnancy plasma was precipitated at 
42% ammonium sulfate saturation and the pellet was 
redissolved in 0.05 M Tris/O.OS M CaC12/0.2 M NaCl, 
pH 7.4 buffer. Samples containing 40-80 pg of SBP/ 
ml or pure SBP (275 yg/ml) were incubated at 4°C 
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for 3 h with 2 nM [3H]androstanolone alone or in 
presence of a IOOO-fold excess of unlabelled andro- 
stanolone. 
Preimmune an&nmune sera were centrifuged at 
1500 X g for 20 min at 4°C to remove cold precipitated 
proteins. Aliquots of 20 ~1 were incubated at 4°C for 
24 h with 100 ~1 of [3H]androstanolone-labelled SBP 
preparation. 
The total incubation media were filtered on ACA 34 
columns (17 X 0.5 cm) previously equilibrated with 
0.05 M Tris/O.OS M CaClJ0.2 M NaCl, pH 7.4 buffer. 
The flow-rate was 3-3.5 ml/h, 0.3 ml fractions were 
collected and counted in a mixture of 3 ml ethanol 
and 10 ml Omnifluor (New England Nuclear) in 
toluene (4 g/litre). All radioactivity measurements 
were made in an Intertechnique SL 30 liquid scintilla- 
tion spectrometer in the precalibrated channel for 
[3H]. Counts were corrected to 100% efficiency by 
external standardization. 
2.6. Preparation of human IgG and transferrin immuno- 
adsorben ts 
Polyacrylamide beads were activated by glutaral- 
dehyde and proteins (IgG or transferrin) were then 
linked batchwise on the gel as described by Ternynck 
and Avrameas [14]. Pure IgG, 6.8 mg, or transferrin 
were dispersed in 6 ml of PBS and mixed with 3 ml 
of glutaraldehyde activated polyacrylamide beads. 
An adsorbent containing 1.1 mg of insolubilized IgG 
or transferrin/ml gel was thus obtained. The adsorbent 
was then extensively washed and 1 ml of crude anti- 
SBP antiserum was added to 1 ml of adsorbent and 
rotated during 48 h at 4°C. The gels were allowed to 
settle and the supernatants were carefully removed. 
The beads were then thoroughly washed with PBS 
and the antibodies adsorbed to the gels were eluted 
by HCl-glycine 0.1 M, pH 2.8 and pH 2.2 [14]. 
2.7. Protein measurements 
The proteins were measured according to Lowry 
[ 151 using bovine serum albumin as standard. 
3. Results 
3.1. Detection of antibodies against SBP 
The elution profile of anti-SBP antiserum previ- 
ously incubated with [3H]androstanolone-SBP is 
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Fig.1. Effluent profiles of Ultrogel ACA 34 gel-filtration. 
Left panel, 100 ~1 of 42% (NH,),SO, human late pregnancy 
plasma precipitate (about 4-8 pg SBP) incubated with 2 nM 
of [ 3H] androstanolone, were filtered (full dots) on a 
-17 X 0.5 cm Ultrogel ACA 34 column. Effluent profiles of 
the same antigen(s) after incubation with preimmune serum 
or antiserum against calf uterus estradiol receptor (empty 
dots - identical curves) and anti-SBP antiserum (stars) are 
shown. Right panel, same incubates, with pure SBP (27.5 fig/ 
100 ~1) instead of human late pregnancy plasma were filtered. 
V.V, Void Volume measured by filtration of Blue Dextran. 
shown on fig. 1. Two radioactive macromolecular 
complexes were observed, the first one (peak A) in 
the void volume, the other one (peak B) in the second 
column volume. [3H]Andro~tanolone labelled SBP, 
when filtered alone, was eluted in the peak B. After 
incubation of anti-SBP antiserum with labelled par- 
tially purified or pure SBP, 20% or 50% of the radio- 
activity of peak B appeared into peak A. This peak A 
was not observed when other antisera such as anti- 
serum against calf uterus estradiol receptor was used 
[loI. 
The two macromolecular entities A and B displayed 
saturable [3H]androstanolone-binding, since no radio- 
activity was observed in both peaks when SBP was 
previously incubated with 2 nM [3H]androstanolone 
plus a 1 OOO-fold excess of unlabelled androstanolone 
before exposure to antiserum (data not shown). 
In other control experiments using rabbit antisera 
alone after incubation with [3H]androstanolone, a 
small but saturable binding of [ 3H] androstanolone 
due to R-TeBG [ 171 was observed in peak B. It 
represented less than 10% of the binding observed in 
SBP gel-filtration experiments and did not modify 
the effluent profiles (data not shown). 
3.2. Specificity of antisera 
In double immunodiffusion experiments, at least 
four precipitin bands were obtained when human 
plasma was reacted with anti-SBP antiserum, while 
one precipitin band was seen with pure SBP (flg.2). 
These results how that the SBP which had been used 
for the first and second immunizations ( ee Materials 
and methods) was not pure. 
The major contaminating antibodies were charac- 
terized by immunoelectrophoresis as anti-transferrin 
and anti-IgG (flg.3) in rabbit and guinea-pig antisera. 
After several booster injections with highly purified 
SBP, the precipitin arcs intensity of contaminating 
Fig.2. Reactivity of pure SBP and transferrin with rabbit anti-SBP antiserum. Central wells contained 10 ~1 crude rabbit antiserum 
(third bleeding). A, in@and @ 10 1.t1 of pure SBP (640 &ml), in@,@and@lO ~1 of human late pregnancy plasma diluted, 
l/32, and in@ 10 ~1 of human transferrin (65 &ml). B, 10 ~1 human late pregnancy plasma diluted l/32 were applied in well@, 
pure SBP (640 &g/ml) in@, human male plasma diluted l/8 in@and human transferrin (65 rg/ml) in@ 
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Fig.3. Identification of the major contaminants in rabbit antiserum. 2 ~1 human late pregnancy plasma diluted l/4 (right upper 
well) and 2 ~1 of ‘pure’ IgC at 100 pg/ml (right lower well) were separated electrophoretically. Then 2 ~1 of pure transferrin at 
65 fig/ml (left upper and lower wells) were added. At the same time 80 ccl of rabbit antiserum were immediately added to the 
trough and the precipitin arcs were formed at 25°C within 24 h. 
__.. ^ _ 
8 
Fig.4. Evidence for a specific anti-SBP antiserum. Rabbit antiserum at tenth bleeding (upper trough) was allowed to react as 
described in Ill.3 against hurn,n late pregnancy plasma diluted l/4 (upper well) and pure SBP (50 fig/ml) (middle well). Part of 
this antiserum immunoadsorbed on insolubilized IgC (lower trough) was allowed to react against SBP (middle well) and whole 
human late pregnancy plasma (lower well). 
Fig.5. Anti-SBP antiserum efficiency measured by double immunodiffusion. 10 ~1 specific anti-SBP antiserum were applied in 
central well. Serial doubling dilutions of human late pregnancy plasma from @ to @ @ = 10 ~1 of non diluted plasma@= 
l/2. . . toa= l/1024,10 rl of pure SBP (160 pg/ml) were applied In@ 
86 
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antibodies was decreased while that of anti-SBP 
antibody was unchanged. Nevertheless, both anti- 
transferrin and anti+@ contaminating antibodies were 
still observed. 
3.3. Purification of rabbit anti-SBPantiserum 
Polyacrylamide-transferrin was ineffective for the 
total purification of anti-SBP antisera. Since the IgG 
preparation used contained traces of transferrin 
(fig.3) the IgG adsorbent was used to remove both 
IgG and transferrin anti-bodies. After immunoadsorp- 
tions, immunoelectrophoresis of the non-adsorbed 
part of the anti-SBP antiserum showed a single 
precipitin arc with whole human late pregnancy plasma 
and with pure SBP (fig.4). 
Only one precipitin arc was still observed in the 
SBP zone with whole human late pregnancy plasma 
and/or male plasma when immunoelectrophoresis 
were performed with different concentrations of 
purified adsorbed anti-SBP antiserum (diluted lo-fold, 
4-fold or concentrated 3-fold). 
The contaminating antibodies, after elution from 
IgG-adsorbent formed three strong precipitin arcs in 
the IgG zone of human plasma and in the transferrin 
and SBP zones. The latter could be due to a contamina- 
tion of IgG by SBP and/or to a non-specific trapping 
of anti-SBP antibodies on the gel. 
3.4. Anti-SBPantiserum efficiency 
Using double immunodiffusion and serial doubling 
dilutions of whole human late pregnancy plasma 
against specific anti-SBP antiserum, SBP was detected 
at a dilution of l/64 (fig.5) and a total identity reac- 
tion was observed between uure SBP and human late 
pregnancy plasma (fig.@ndo>. 
4. Discussion 
The preparation of partially purified SBP was used 
to obtain antibodies against SBP which were detected 
by gel-filtration and immunodiffusion in agarose-gel. 
Gel-filtration experiments showed that a large* 
macro-molecular complex was formed when SBP 
labelled with [ 3H] androstanolone was previously 
incubated with non purified anti-SBP, antiserum and 
was eluted into the void volume of the column (fig. 1, 
peak A). Appropriate controls indicated that the 
formation of this complex was due to an antibody- 
SBP interaction. 
However, these crude antisera were not specific. 
This was largely due to the difficulty to obtain 
absolutely pure SBP. Transferrin and IgG were the 
main contaminating proteins. The presence of IgG 
in SBP preparations has been already reported by 
Bohn [18] who showed that IgG was the major con- 
taminant of his SP2 preparation, which he suspected 
to be SBP. Recently, Zoller [ 191 confirmed that 
mainly transferrin and IgG of human plasma were 
non-specifically bound to affinity columns and retain- 
ed by hydrophobic retention or trapping. These 
findings could explain why IgG and transferrin were 
contaminating our SBP preparation because of the 
use of affinity resin. 
The presence in the partially purified SBP prepara- 
tions of trace amounts of IgG and transferrin were 
not detected in PAGE since transferrin was not 
separated from SBP in such a system [8] and the 
amount of IgG was too slight to be visualized. Both 
proteins were only detected by immunoelectrophoresis. 
Immunogenicity of IgG is very strong and, conse- 
quently, significant amounts of anti-&G were pro- 
duced by the animals when trace amounts of IgG 
were present in the SBP preparations. Therefore these 
crude antisera are very useful to monitor the purifica- 
tion of SBP. 
Booster injections made with immunologically and 
electrophoretically pure SBP had improved the speci- 
ficity of anti-SBP antisera, but contaminating anti- 
transferrin and anti-IgG were still present. 
Immunoadsorption of rabbit anti-SBP antiserum 
on a synthetic IgG-adsorbent removed both anti-trans- 
ferrin and anti-IgG and a specific anti-SBP antiserum 
could then be obtained. This anti-SBP antiserum gives 
one precipitin band against either human late preg- 
nancy plasma or pure SBP with immunoelectrophoresis 
and double immunodiffusion. 
Work is now in progress on the immunological titra- 
tion of SBP with glucose-oxidase-linked antibodies 
and will be correlated to values previously obtained 
by steroid-binding. Specific anti-SBP antiserum will 
also be used in immunohistochemical studies. 
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